Skip to main content
. 2023 Jan 10;15(1):193. doi: 10.3390/v15010193

Figure 2.

Figure 2

Analysis of primary and secondary endpoints at times 24, 36, and 48 for HBcAb-positive vs. HBcAb-negative patients.